{
  "schema_version": "2.0",
  "doc_id": "a98dd4fe258c7fd81b667424ee32d2074868becdf3221a95d8de821a93ac441e",
  "extracted_at": "2026-02-01T08:53:14.539633+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "obesity-induced increases"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_002",
      "type": "PharmEffect",
      "name": "inflammatory",
      "attributes": {
        "context": "inflammatory cytokines"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_003",
      "type": "PharmEffect",
      "name": "anxiety-like behaviors",
      "attributes": {
        "context": "increased anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_004",
      "type": "Indication",
      "name": "Obesity",
      "attributes": {
        "context": "Obesity was studied"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_005",
      "type": "PharmEffect",
      "name": "inflammatory",
      "attributes": {
        "context": "inflammatory pathways"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_006",
      "type": "Compound",
      "name": "ibuprofen",
      "attributes": {
        "context": "oral ibuprofen"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_007",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "TNF-\u03b1 blocker"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_008",
      "type": "Compound",
      "name": "etanercept",
      "attributes": {
        "context": "TNF-\u03b1 blocker etanercept"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_009",
      "type": "Indication",
      "name": "obese",
      "attributes": {
        "context": "obese male mice"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_010",
      "type": "PharmEffect",
      "name": "anxiety-like behaviors",
      "attributes": {
        "context": "elevated anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_011",
      "type": "PharmEffect",
      "name": "pro-inflammatory",
      "attributes": {
        "context": "pro-inflammatory cytokines"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_012",
      "type": "PharmEffect",
      "name": "Anti-inflammatory",
      "attributes": {
        "context": "Anti-inflammatory treatments"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_013",
      "type": "Compound",
      "name": "ibuprofen",
      "attributes": {
        "context": "oral ibuprofen"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_014",
      "type": "PharmEffect",
      "name": "ameliorated anxiety-like behaviors",
      "attributes": {
        "context": "ameliorated anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_015",
      "type": "Compound",
      "name": "ibuprofen",
      "attributes": {
        "context": "ibuprofen and CFR treatments"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_016",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "hippocampal TNF-\u03b1 expression"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_017",
      "type": "PharmEffect",
      "name": "pro-inflammatory",
      "attributes": {
        "context": "pro-inflammatory cytokines"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_018",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "increased TNF-\u03b1 in the brain"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_019",
      "type": "PharmEffect",
      "name": "anxiety-like behaviors",
      "attributes": {
        "context": "increases in anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_020",
      "type": "Indication",
      "name": "obese",
      "attributes": {
        "context": "obese mice"
      },
      "source_chunk_ids": [
        "7ae73eca45d3ecf465f08a11c0b9b0ba"
      ]
    },
    {
      "id": "ent_021",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "The role of TNF-\u03b1 in modulating anxiety"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_022",
      "type": "Compound",
      "name": "etanercept",
      "attributes": {
        "context": "the TNF-\u03b1 blocker etanercept into the brain"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "modulating anxiety",
      "attributes": {
        "context": "in modulating anxiety was subsequently determined"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_024",
      "type": "PharmEffect",
      "name": "anxiety-like behaviors",
      "attributes": {
        "context": "impact on anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_025",
      "type": "PharmEffect",
      "name": "synaptic transmission",
      "attributes": {
        "context": "synaptic transmission in the ventral hippocampus"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_026",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "modulating anxiety"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_027",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_028",
      "type": "Compound",
      "name": "Etanercept",
      "attributes": {
        "context": "Etanercept selectively reduced anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_029",
      "type": "PharmEffect",
      "name": "reduced anxiety-like behaviors",
      "attributes": {
        "context": "Etanercept selectively reduced anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_030",
      "type": "Indication",
      "name": "obese",
      "attributes": {
        "context": "in obese db/db mice"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_031",
      "type": "PharmEffect",
      "name": "anxiety-related behaviors",
      "attributes": {
        "context": "increases in anxiety-related behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_032",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "dependent on TNF-\u03b1 signaling"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_033",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "anxiety-related behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_034",
      "type": "PharmEffect",
      "name": "synaptic transmission",
      "attributes": {
        "context": "Changes in synaptic transmission in the hippocampus"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_035",
      "type": "PharmEffect",
      "name": "anxiety behaviors",
      "attributes": {
        "context": "underlie anxiety behaviors in obese mice"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_036",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "anxiety behaviors"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_037",
      "type": "Indication",
      "name": "obese",
      "attributes": {
        "context": "in obese mice"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "TNF-\u03b1 inhibition diminished the frequency"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_039",
      "type": "PharmEffect",
      "name": "TNF-\u03b1 inhibition",
      "attributes": {
        "context": "TNF-\u03b1 inhibition diminished the frequency"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_040",
      "type": "PharmEffect",
      "name": "diminished the frequency and amplitude of excitatory postsynaptic currents",
      "attributes": {
        "context": "diminished the frequency and amplitude of excitatory postsynaptic currents"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_041",
      "type": "PharmEffect",
      "name": "mood regulation",
      "attributes": {
        "context": "associated with mood regulation"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "Etanercept",
      "attributes": {
        "context": "Etanercept injections are currently used clinically"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_043",
      "type": "PharmEffect",
      "name": "chronic inflammation",
      "attributes": {
        "context": "conditions of chronic inflammation"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_044",
      "type": "Indication",
      "name": "chronic inflammation",
      "attributes": {
        "context": "conditions of chronic inflammation"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_045",
      "type": "Indication",
      "name": "rheumatoid arthritis",
      "attributes": {
        "context": "including rheumatoid arthritis"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_046",
      "type": "Indication",
      "name": "psoriasis",
      "attributes": {
        "context": "and psoriasis"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_047",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "this TNF-\u03b1 blocker could be a promising therapeutic candidate"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_048",
      "type": "PharmEffect",
      "name": "therapeutic",
      "attributes": {
        "context": "a promising therapeutic candidate"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_049",
      "type": "PharmEffect",
      "name": "treating anxiety",
      "attributes": {
        "context": "for treating anxiety in obese individuals"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_050",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "treating anxiety in obese individuals"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_051",
      "type": "Indication",
      "name": "obese",
      "attributes": {
        "context": "in obese individuals"
      },
      "source_chunk_ids": [
        "264103cd0e118324d664c2771c8af695"
      ]
    },
    {
      "id": "ent_052",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "obesity rates are higher"
      },
      "source_chunk_ids": [
        "e8379c632ac217cc2a7d179199c87dfd"
      ]
    },
    {
      "id": "ent_053",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "suffer from anxiety"
      },
      "source_chunk_ids": [
        "e8379c632ac217cc2a7d179199c87dfd"
      ]
    },
    {
      "id": "ent_054",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "lead to the anxiety bias"
      },
      "source_chunk_ids": [
        "e8379c632ac217cc2a7d179199c87dfd"
      ]
    },
    {
      "id": "ent_055",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "in the context of obesity"
      },
      "source_chunk_ids": [
        "e8379c632ac217cc2a7d179199c87dfd"
      ]
    },
    {
      "id": "ent_056",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "prevalence of obesity in humans"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_057",
      "type": "Concentration",
      "name": "42.8%",
      "attributes": {
        "context": "adults is 42.8%"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_058",
      "type": "Concentration",
      "name": "20.6%",
      "attributes": {
        "context": "that, 20.6%"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "neuroinflammatory responses",
      "attributes": {
        "context": "modulates neuroinflammatory responses"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "TNF-alpha",
      "attributes": {
        "context": "efficacy of a TNF-alpha blocker"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "etanercept",
      "attributes": {
        "context": "blocker like etanercept"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_062",
      "type": "PharmEffect",
      "name": "reducing anxiety-like behaviors",
      "attributes": {
        "context": "in reducing anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_063",
      "type": "Indication",
      "name": "anxiety-like behaviors",
      "attributes": {
        "context": "reducing anxiety-like behaviors"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_064",
      "type": "Compound",
      "name": "TNF-alpha",
      "attributes": {
        "context": "by which TNF-alpha targets"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_065",
      "type": "Indication",
      "name": "anxiety disorders",
      "attributes": {
        "context": "treating anxiety disorders"
      },
      "source_chunk_ids": [
        "daf16cd30d7c3df2711e042eff9dfb9c"
      ]
    },
    {
      "id": "ent_066",
      "type": "Indication",
      "name": "mood disorders",
      "attributes": {
        "context": "may cause mood disorders"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_067",
      "type": "Indication",
      "name": "treatment resistance",
      "attributes": {
        "context": "high rate of treatment resistance"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_068",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "contributing to anxiety"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_069",
      "type": "Indication",
      "name": "depressive disorders",
      "attributes": {
        "context": "and depressive disorders"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_070",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "role for TNF-\u03b1 in obesity-associated anxiety"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_071",
      "type": "Indication",
      "name": "obesity-associated anxiety",
      "attributes": {
        "context": "in obesity-associated anxiety"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_072",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "in the context of obesity"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_073",
      "type": "Indication",
      "name": "anxiety disorders",
      "attributes": {
        "context": "targeting anxiety disorders"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_074",
      "type": "Indication",
      "name": "neuroimmune activation",
      "attributes": {
        "context": "lead to neuroimmune activation"
      },
      "source_chunk_ids": [
        "93c611d3eb33ef56d0c2d276ae38bb64"
      ]
    },
    {
      "id": "ent_075",
      "type": "Compound",
      "name": "tumor necrosis factor-alpha",
      "attributes": {
        "context": "Brain tumor necrosis factor-alpha mediates"
      },
      "source_chunk_ids": [
        "e612f901668b135c2773a53bb22af559"
      ]
    },
    {
      "id": "ent_076",
      "type": "PharmEffect",
      "name": "anxiety-like behavior",
      "attributes": {
        "context": "mediates anxiety-like behavior"
      },
      "source_chunk_ids": [
        "e612f901668b135c2773a53bb22af559"
      ]
    },
    {
      "id": "ent_077",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "The impact of obesity and hypercaloric diet consumption on anxiety"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_078",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "on anxiety and emotional behavior across the lifespan"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_079",
      "type": "PharmEffect",
      "name": "emotional behavior",
      "attributes": {
        "context": "on anxiety and emotional behavior across the lifespan"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_080",
      "type": "Indication",
      "name": "adiposity",
      "attributes": {
        "context": "Relationship between adiposity, emotional status and eating behaviour"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_081",
      "type": "PharmEffect",
      "name": "emotional status",
      "attributes": {
        "context": "adiposity, emotional status and eating behaviour in obese women"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_082",
      "type": "PharmEffect",
      "name": "eating behaviour",
      "attributes": {
        "context": "emotional status and eating behaviour in obese women"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_083",
      "type": "Indication",
      "name": "inflammation",
      "attributes": {
        "context": "role of inflammation"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_084",
      "type": "Indication",
      "name": "inflammation",
      "attributes": {
        "context": "From inflammation to sickness and depression"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_085",
      "type": "Indication",
      "name": "sickness",
      "attributes": {
        "context": "From inflammation to sickness and depression"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_086",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "to sickness and depression: when the immune system subjugates the brain"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_087",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "Sex differences in anxiety and emotional behavior"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_088",
      "type": "PharmEffect",
      "name": "emotional behavior",
      "attributes": {
        "context": "Sex differences in anxiety and emotional behavior"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_089",
      "type": "Compound",
      "name": "tumor necrosis factor-alpha",
      "attributes": {
        "context": "Brain tumor necrosis factor-\u03b1 mediates anxiety-like behavior"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_090",
      "type": "PharmEffect",
      "name": "anxiety-like behavior",
      "attributes": {
        "context": "Brain tumor necrosis factor-\u03b1 mediates anxiety-like behavior"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_091",
      "type": "Indication",
      "name": "severe obesity",
      "attributes": {
        "context": "in a mouse model of severe obesity"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_092",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "Prevalence of obesity among adults and youth"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_093",
      "type": "Compound",
      "name": "tumor necrosis factor-alpha",
      "attributes": {
        "context": "Adipose expression of tumor necrosis factor-\u03b1: direct role"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_094",
      "type": "Indication",
      "name": "obesity-linked insulin resistance",
      "attributes": {
        "context": "in obesity-linked insulin resistance"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_095",
      "type": "Compound",
      "name": "tumor necrosis factor antagonist",
      "attributes": {
        "context": "A randomized controlled trial of the tumor necrosis factor antagonist infliximab"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_096",
      "type": "Compound",
      "name": "infliximab",
      "attributes": {
        "context": "the tumor necrosis factor antagonist infliximab for treatment-resistant depression"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_097",
      "type": "Indication",
      "name": "treatment-resistant depression",
      "attributes": {
        "context": "infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_098",
      "type": "PharmEffect",
      "name": "inflammatory",
      "attributes": {
        "context": "the role of baseline inflammatory biomarkers"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_099",
      "type": "Indication",
      "name": "Obesity",
      "attributes": {
        "context": "Obesity is associated with hypothalamic injury in rodents and humans"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_100",
      "type": "Indication",
      "name": "hypothalamic injury",
      "attributes": {
        "context": "associated with hypothalamic injury in rodents and humans"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    },
    {
      "id": "ent_101",
      "type": "Indication",
      "name": "Obesity",
      "attributes": {
        "context": "Obesity is associated with macrophage accumulation in adipose tissue"
      },
      "source_chunk_ids": [
        "5ad7b4d387e61e0bd23bf89b2b87f14b"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:04.070796+00:00",
    "original_file": "entities.json"
  }
}